All News

Intravenous immunoglobulin shows promise as a treatment option for pregnant patients with SARS-CoV-2, influenza, and other respiratory viruses.

Goal of modernizing therapeutic equivalence rating determination act is to increase availability, competition, drive down prescription costs.

:Simeprevir (Olysio) is an NS3/4A protease inhibitor indicated for the treatment of chronic hepatitis C infection as a component of a combination antiviral treatment regimen.

Docusate treats occasional constipation by reducing surface tension and emulsification of fecal matter, which allows water to penetrate and mix with and soften stool.

Antibody levels against SARS-CoV-2 1 month after the booster dose were increased compared to before the booster dose in children 5 to 11 years of age.

The FDA previously placed a clinical hold on lenacapavir in borosilicate vials in all clinical studies because of emerging concerns about the compatibility of vials made of borosilicate glass.

Physicians often overlook those with lower BMIs who have nonalcoholic fatty liver disease and lower rates of other comorbidities, investigators say.

Analysis shows the activity of a specific enzyme, Butyrylcholinesterase, was significantly lower in those who subsequently died of sudden infant death syndrome.

Combining nicotine replacement therapy and varenicline is often most successful, but pharmacists can help patients find best approach.

The Labcorp Seasonal Respiratory Virus RT-PCR DTC Test is the first direct-to-consumer multi-analyte COVID-19 test to be authorized by FDA.

On this week's episode, Joanna interviews Michelle Tam, the creator of the food blog, Nom Nom Paleo.

Educate patients about how to purchase and store medical products without hoarding resources.

Many patients turn to fish oil supplements to gain the benefits of omega-3 fatty acids, but there are important considerations pharmacists should be aware of before recommending fish oil supplements to their customers.

Naxitamab-gqgk (Danyelza) is for the treatment of pediatric and adult patients with relapsed or refractory high-risk neuroblastoma in the bone or bone marrow who have demonstrated a partial response, minor response, or stable disease to prior therapy.

Uristat helps to alleviate symptoms caused by urinary tract infection (UTI), including pain, burning, and needing to urinate urgently.

Ribociclib plus fulvestrant achieved a median overall survival of 67.6 months in the first line setting for postmenopausal women with HR-positive/HER2-negative advanced breast cancer.

Infections at community hospitals fell by 63% after 1 year and 77% after 3 years, new data show.

Individuals who have recovered from the initial disease are in generally poorer health later on compared with the general population, the analysis shows.

One of PQA's quantitative research projects that they are working on now is looking at how medication adherence is related to outcomes.

Asundexian was granted FDA Fast Track Designation based on a phase 2 study evaluating its safety and efficacy combined with antiplatelet therapy in patients following an acute, non-cardioembolic ischemic stroke.

Health care policy decisions based on sound data and research are essential for addressing the challenges.

Many of patients with hepatitis that pharmacists encounter have viral hepatitis, which can be easily remembered as the ABCs of hepatitis.

Health care and public health officials are concerned over the number of missed or declined immunizations, but the pharmacy can play a role in turning this tide.

Tirzepatide is a once-weekly glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist indicated as an adjunct to diet and exercise in adults with type 2 diabetes.

Atezolizumab (Tecentriq) is indicated for use in urothelial carcinoma, non-small cell lung cancer, triple-negative breast cancer, small cell lung cancer, hepatocellular carcinoma, and melanoma.

Dramamine Ginger Chews are designed for non-drowsy relief of multiple causes of nausea.

Investigators analyzed data from nearly 4000 individuals from the National Longitudinal Study of Adolescent to Adult Health.

The findings suggest that the broad use of race as a factor for providing certain health interventions and treatments should be reconsidered, investigators say.